Terry Plasse News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Metro Detroit residents needed for oral COVID-19 treatment clinical trial Metro Detroit residents who have been recently diagnosed with COVID-19 or are currently ill after being exposed are needed for a clinical trial for a new virus treatment. Phase 2/3 of the national study will examine the safety and efficacy of Raleigh, North Carolina-based RedHill Biopharma's drug RHB-107, or upamostat. The medication is an orally administered serine protease inhibitor with antiviral and potential tissue-protective effects that target human cells rather than the COVID-19 virus itself Researchers are e...

COVID-19 treatment clinical trial seeks participants in Cleveland The study is seeking participants who have recently being diagnosed or patients who have not yet been diagnosed by show symptoms and were exposed. Author: WKYC Staff Updated: 1:49 PM EDT April 27, 2021 CLEVELAND — is from a previous report. As the state Ohio continues its fight against the Coronavirus pandemic, health officials are still working to find cures and treatments for the disease.  A new clinical trial, hoping to treat COVID-19 patients, is seek participants in Cleveland to take pa...

Share this article NEW YORK, March 2, 2021 /PRNewswire/ -- ObvioHealth, a global virtual research organization or VRO, today announced the launch of a hybrid clinical trial for the treatment of COVID-19, using an innovative study design with digital data capture to remotely monitor patient vitals. This U.S. Phase 2/3 study will examine the safety and efficacy of RedHill Biopharma's (Nasdaq: RDHL) RHB-107 (upamostat), using ObvioHealth's clinical trial ecosystem, including digital devices, a patient-centric smartphone application and home healthcare visits. RHB-107 is a novel, orally-adminis...